multiplex ihc as biomarkers for cancer immunotherapy
Published 7 years ago • 855 plays • Length 8:52Download video MP4
Download video MP3
Similar videos
-
4:40
highly multiplexed ihc assays to examine immune checkpoints and biomarkers for immunotherapy
-
44:56
multiplex ihc and novel monoclonal antibodies as enabling tools for the study of tumor immunology
-
5:23
mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy
-
6:47
new biomarkers for response to immunotherapy
-
53:17
analysis of immune checkpoints in breast and ovarian cancer using multiplex immunohistochemistry
-
33:09
webinar | making 7-color multiplex fluorescent ihc a breeze
-
2:33
genomic profiling of pscc reveals major biomarkers for the efficacy of immunotherapy
-
42:53
biomarkers in cancer immunotherapy: how much do they matter?
-
32:54
role of genomics in identifying biomarkers for response and resistance to anti-cancer immunotherapy
-
5:16
predictive biomarkers for immunotherapy in upper gi cancers
-
0:58
immune checkpoint inhibitors: recent progress and potential biomarkers - 3iii pd-l1 overexpression
-
52:05
myeloid immunosuppression in the tumor microenvironment characterized by single/multiplex ihc
-
1:05:53
cancer immunotherapy beyond 2020
-
37:31
update on immuno-oncology biomarkers
-
39:55
new checkpoints and biomarkers
-
1:11:32
refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
-
1:29
the challenges of using biomarkers for immunotherapy
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 3iv pd-l1 overexpression